Inside U.S. Regulations
This episode covers critical developments across multiple regulatory sectors including Draft Guidance, Capital Markets, Cancer Drugs, Regulation Best Interest, and Enforcement. Highlights include the US Securities and Exchange Commission’s enforcement actions against David Lerner Associates for violations of Regulation Best Interest, emphasizing the importance of compliance in broker-dealer recommendations. The International Organization of Securities Commissions (IOSCO) has released a comprehensive AI Supervisory Toolkit to help regulators manage AI-related risks in capital markets, promoting transparency and investor protection. Additionally, the US Food and Drug Administration has introduced draft guidance aimed at reducing unnecessary animal testing in cancer drug development by advocating for evidence-based alternatives and streamlined testing protocols. For more information, visit the Carver Agents website [https://carveragents.ai]. Articles mentioned: 1. ASC issues cease-and-desist letters to prevent further harm to victims of BG Wealth Sharing as scam collapses [https://asc.ca/News-and-Publications/News-Releases/2026/05/25-ASC-issues-cease-and-desist-letters-to-prevent-further-harm-to-victims-of-BG-Wealth-Sharing] 2. Federal Reserve Board issues enforcement actions with former employee of Atlantic Union Bank and former employee of Frost Bank [https://www.federalreserve.gov/newsevents/pressreleases/enforcement20260528a.htm] 3. Tawon Liar contains hidden drug ingredient [http://www.fda.gov/drugs/medication-health-fraud/tawon-liar-contains-hidden-drug-ingredient] 4. FSIS Issues Public Health Alert for Beef Kofta Products Served at The Kebab Shop Restaurant Locations Due to Possible E. Coli O157:H7 Contaminationpha [https://tools.cdc.gov/api/embed/downloader/download.asp?m=379374&c=765627] 5. FP Operations Ltd. [https://www.osc.ca/en/securities-law/orders-rulings-decisions/fp-operations-ltd] 6. IOSCO publishes AI Supervisory Toolkit [https://www.iosco.org/news/pdf/IOSCONEWS796.pdf] 7. FDA Issues Draft Guidance to Cut Unnecessary Animal Testing for Cancer Drugs [http://www.fda.gov/news-events/press-announcements/fda-issues-draft-guidance-cut-unnecessary-animal-testing-cancer-drugs] 8. Remarks at the Stanford Rock Center for Corporate Governance [https://www.sec.gov/newsroom/speeches-statements/atkins-052626-remarks-stanford-rock-center-corporate-governance] 9. David Lerner Associates, Inc. [https://www.sec.gov/files/litigation/admin/2026/34-105556.pdf] 10. Information about Domperidone [http://www.fda.gov/drugs/investigational-new-drug-ind-application/information-about-domperidone]
18 afleveringen
Reacties
0Wees de eerste die een reactie plaatst
Meld je nu aan en word lid van de Inside U.S. Regulations community!